J. Goldman & CO LP Scholar Rock Holding Corp Transaction History
J. Goldman & CO LP
- $2.89 Billion
- Q1 2024
A detailed history of J. Goldman & CO LP transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, J. Goldman & CO LP holds 98,388 shares of SRRK stock, worth $819,572. This represents 0.06% of its overall portfolio holdings.
Number of Shares
98,388Holding current value
$819,572% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding SRRK
# of Institutions
165Shares Held
73.6MCall Options Held
501KPut Options Held
26.3K-
Artal Group S.A. Luxembourg, N411.3MShares$93.8 Million10.78% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.21MShares$68.4 Million0.02% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA6.79MShares$56.5 Million38.03% of portfolio
-
Redmile Group, LLC San Francisco, CA6.42MShares$53.5 Million4.49% of portfolio
-
Black Rock Inc. New York, NY5.01MShares$41.7 Million0.0% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $430M
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...